Skip to main content
. 2011 Aug 2;105(6):773–777. doi: 10.1038/bjc.2011.285

Table 2. Characteristics of the 41 enrolled patients.

Characteristic Schedule A Schedule B Total
Number of patients 19 22 41
       
Age, years
 Median 54 54 54
 Range 35–76 25–81 25–81
       
Sex
 Male 10 (53%) 13 (59%) 23 (56%)
 Female 9 (47%) 9 (41%) 18 (44%)
       
Ethnic origin
 White 19 (100%) 21 (96%) 40 (98%)
 Black 0 1 (4%) 1 (2%)
       
ECOG performance status
 0 6 (32%) 8 (36%) 14 (34%)
 1 11 (58%) 14 (64%) 25 (61%)
 2 1 (5%) 0 1 (2%)
 Unknown 1 (5%) 0 1 (2%)
       
Histopathology
 Melanoma 14 (74%) 22 (100%) 36 (87%)
 Adenocarcinoma, NOS 3 (16%) 0 3 (7%)
 Mucinous adenocarcinoma 1 (5%) 0 1 (2%)
 Small-cell carcinoma, NOS 1 (5%) 0 1 (2%)
       
Previous therapy
 Chemotherapy 7 (37%) 4 (18%) 11 (27%)
 Immunotherapy 10 (53%) 13 (59%) 23 (56%)
 Radiation 4 (21%) 4 (18%) 8 (20%)
 Other 4 (21%) 1 (4%) 5 (12%)

Abbreviations: ECOG=Eastern Cooperative Oncology Group; NOS=not otherwise specified.